AtriCure cryoICE cryoSPHERE Cryoablation System
Device Cardiovascular
PDI 10840143902543
General payments
$4,321,096
Research payments
$1,404,675
Through program year 2025, $4,321,096 in general payments and $1,404,675 in research payments were reported against AtriCure cryoICE cryoSPHERE Cryoablation System (Cardiovascular).
No combined total These are different kinds of money, reported under different rules. A meal and a clinical trial grant do not add up to anything meaningful, so this site does not add them.
By program year
10 rows| Year | Kind | Amount | Payments |
|---|---|---|---|
| 2025 | General | $928,054 | 6,227 |
| 2025 | Research | $415,676 | 178 |
| 2024 | General | $1,344,780 | 7,917 |
| 2024 | Research | $267,070 | 184 |
| 2023 | General | $582,706 | 2,845 |
| 2023 | Research | $451,104 | 321 |
| 2022 | General | $308,842 | 1,126 |
| 2022 | Research | $268,125 | 102 |
| 2021 | General | $1,156,713 | 3,887 |
| 2021 | Research | $2,700 | 1 |
Breakdown
The top 5 of the 100 largest recipients; each share is of general payments naming this product in 2025.
The top 5 of 94 specialties; each share is of general payments naming this product to practitioners with a specialty in 2025. Each practitioner is counted under their primary specialty.
The top 5 of 49 states; each share is of general payments naming this product in 2025 where a state was reported.
Records
22,002 general · 786 researchEvery payment, record by record
Date, amount, who was paid and what for — filter by year and kind, or download as CSV, free, in files of 5,000 rows.
What you are looking at
Manufacturers name the drug, biological or device a payment relates to. CMS does not give products their own identifiers, so a product here is assembled from how it was reported — a brand may appear under more than one spelling, and this page covers one of them rather than the brand as a whole.